The present invention relates to novel compounds with a variety of therapeutic uses, more particularly novel prodrugs that are particularly useful for delivering a parent compound for selective estrogen receptor modulation.
-
Page/Page column 30; 38-40
(2010/02/11)
More Articles about upstream products of 850005-34-4